All In Biotech

Drug Trial Radar · NCT06993792

A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes

A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Tablet Once Daily Compared With Placebo in Participants With Obesity or Overweight With and Without Type 2 Diabetes

Last checked: Nov 20, 2026Latest source record: Jul 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 1,400 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

1,400

Planned (sponsor's estimate)

Start

May 15, 2025

Primary completion

Aug 2027

Study completion Aug 2027

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
May 29, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Screening
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this Master Protocol is to support two studies to see how well and how safely orforglipron works compared to placebo in participants who have obesity or overweight with or without type 2 diabetes. Participants will be screened for about 4 weeks, after which they will enroll into either J2A-MC-GZP1, NCT06972459 (do not have type 2 diabetes) or J2A-MC-GZP2, NCT06972472 (have type 2 diabetes).

Conditions

  • Obesity
  • Overweight
  • Type 2 Diabetes

Interventions

  • OrforglipronDrug

    Administered orally

  • PlaceboDrug

    Administered orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants Allocated to Each StudyTime frame: Baseline to Week 4

Locations

80 sites in 7 countries. Site status is shown where the registry gives one.

  • Clinical Research Institute of Arizona (CRI) - Sun City West

    Sun City West, Arizona

  • Novak Clinical Research - Tucson - North La Cholla Boulevard

    Tucson, Arizona

  • Norcal Endocrinology & Internal Medicine

    San Ramon, California

  • Southern California Clinical Research

    Santa Ana, California

  • Care Access - Thousand Oaks

    Thousand Oaks, California

  • Accel Research Sites - DeLand Clinical Research Unit

    DeLand, Florida

  • Innovation Medical Research Center - Fort Lauderdale

    Fort Lauderdale, Florida

  • Indago Research & Health Center, Inc

    Hialeah, Florida

  • Encore Medical Research

    Hollywood, Florida

  • West Orange Endocrinology P.A.

    Ocoee, Florida

  • Care Access - Tampa

    Tampa, Florida

  • Conquest Research

    Winter Park, Florida

  • Accel Research Sites - NeuroStudies Clinical Research Unit

    Decatur, Georgia

  • Care Access - Decatur

    Decatur, Georgia

  • Javara - Privia Medical Group Georgia - Savannah

    Savannah, Georgia

  • North Georgia Clinical Research

    Woodstock, Georgia

  • Solaris Clinical Research

    Meridian, Idaho

  • Care Access - New Iberia

    New Iberia, Louisiana

  • Endocrine and Metabolic Consultants

    Rockville, Maryland

  • Javara - Privia Medical Group - Silver Spring

    Silver Spring, Maryland

  • Great Lakes Research Group, Inc.

    Bay City, Michigan

  • Boeson Research MSO

    Missoula, Montana

  • Javara - Nevada Health Centers - Carson City

    Carson City, Nevada

  • The Machuca Foundation

    Las Vegas, Nevada

  • University of North Carolina Medical Center

    Chapel Hill, North Carolina

  • Javara - Tryon Medical Partners

    Charlotte, North Carolina

  • Care Access - Fayetteville

    Fayetteville, North Carolina

  • The Corvallis Clinic, P.C.

    Corvallis, Oregon

  • Clinical Research of Philadelphia

    Philadelphia, Pennsylvania

  • Frontier Clinical Research, LLC

    Smithfield, Pennsylvania

  • Velocity Clinical Research, Dallas

    Dallas, Texas

  • Biopharma Informatic, LLC

    Houston, Texas

  • Activian Clinical Research

    Kingwood, Texas

  • Texas Valley Clinical Research (TVCR) - Mission

    Mission, Texas

  • Consano Clinical Research, LLC

    Shavano Park, Texas

  • CARE - Centro de Alergia y Enfermedades Respiratorias

    Buenos Aires, Argentina

  • CIPREC

    Buenos Aires, Argentina

  • Centro Médico Viamonte

    Buenos Aires, Argentina

  • Instituto Centenario

    CABA, Argentina

  • Instituto Médico Catamarca IMEC

    Rosario, Argentina

Showing 40 of 80 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.